NCT03680677 | Leukemia, Acute
... more >> MDS Collapse << | Not Applicable | Not yet recruiting | November 2025 | United States, Pennsylvania
... more >>
Abramson Cancer Center of the University of Pennsylvania
Not yet recruiting
Philadelphia, Pennsylvania, United States, 19104 Collapse << |
NCT02665065 | Acute Myeloid Leukemia
... more >> Leukemia, Acute Myeloid
Myeloid Leukemia, Acute
Leukemia, Myeloid, Acute
Acute Myelogenous Leukemia
Leukemia, Acute Myelogenous
Myelogenous Leukemia, Acute Collapse << | Phase 3 | Recruiting | June 2020 | United States, Arizona
... more >>
Banner MD Anderson Cancer Center
Recruiting
Gilbert, Arizona, United States
United States, Connecticut
Yale Cancer Center
Recruiting
New Haven, Connecticut, United States
United States, Florida
Mayo Clinic
Recruiting
Jacksonville, Florida, United States
United States, Illinois
Loyola University Medical Center
Recruiting
Maywood, Illinois, United States
United States, Kansas
The University of Kansas Cancer Center
Recruiting
Westwood, Kansas, United States
United States, Minnesota
Mayo Clinic
Recruiting
Rochester, Minnesota, United States
United States, Missouri
Washington University School of Medicine
Recruiting
Saint Louis, Missouri, United States
United States, Nebraska
University of Nebraska Medical Center
Recruiting
Omaha, Nebraska, United States
United States, New York
Roswell Park Cancer Institute
Recruiting
Buffalo, New York, United States
Memorial Sloan Kettering Cancer Center
Recruiting
New York, New York, United States
Stony Brook University
Recruiting
Stony Brook, New York, United States
United States, Ohio
University Hospital of Cleveland Seidman Cancer Center
Recruiting
Cleveland, Ohio, United States
The Ohio State University Comprehensive Cancer Center
Recruiting
Columbus, Ohio, United States
United States, Texas
Baylor Charles A. Sammons Cancer Center
Recruiting
Dallas, Texas, United States
MD Anderson Cancer Center
Recruiting
Houston, Texas, United States
United States, Washington
Fred Hutchinson Cancer Research Center
Recruiting
Seattle, Washington, United States
United States, Wisconsin
Medical College of Wisconsin
Recruiting
Milwaukee, Wisconsin, United States
Canada, Ontario
University of Ottawa
Recruiting
Ottawa, Ontario, Canada Collapse << |
NCT02428543 | Acute Myeloid Lukemia | Phase 1
Phase 2 | Recruiting | September 2020 | France
... more >> Dr Abdelaziz CHAIB
Recruiting
Aix-en-Provence, France, 13600
Contact: Abdelaziz CHAIB achaib@ch-aix.fr
Principal Investigator: Abdelaziz CHAIB
Chu Amiens
Recruiting
Amiens, France, 80054
Contact: MAROLLEAU Jean Pierre
Principal Investigator: MAROLLEAU Jean Pierre
CHU d'Angers
Recruiting
Angers, France, 49033
Contact: Martine GARDEMBAS Magardembas@chu-angers.fr
Principal Investigator: Martine GARDEMBAS
Hôpital VICTOR DUPOUY
Recruiting
Argenteuil, France, 95107
Contact: AL JIJAKLI Ahmad ahmad.aljijakli@ch-argenteuil.fr
Principal Investigator: AL JIJAKLI Ahmad
Dr Edouard RANDIAMALALA
Recruiting
Bayonne, France, 64100
Contact: Edouard RANDIAMALALA erandiamalala@ch-cotebasque.fr
Principal Investigator: Edouard RANDIAMALALA
CHU de Besançon
Recruiting
Besançon, France, 25030
Contact: Fabrice LAROSA flarosa@chu-besançon.fr
Principal Investigator: Fabrice LAROSA
Dr Thorsten BRAUN
Recruiting
Bobigny, France, 93000
Contact: Thorsten BRAUN thorsten.braun@aphp.fr
Principal Investigator: Thorsten BRAUN
CHU Boulogne Sur Mer
Recruiting
Boulogne Sur Mer cedex, France, 62321
Contact: CHOUFI Bachra b.choufi@ch-boulogne.fr
Principal Investigator: CHOUFI Bachra
Chr Clemenceau
Recruiting
Caen Cedex, France, 14033
Contact: REMAN Oumédaly reman-o@chu-caen.fr
Principal Investigator: REMAN Oumédaly
Hôpital d'Instruction des Armées PERCY
Recruiting
Clamart, France, 92141
Contact: Jean Valère MALFUSSON jvmalf@free.fr
Principal Investigator: Jean Valère MALFUSSON
Dr Stéphanie HAÏAT
Recruiting
Corbeil-essonnes, France, 91100
Contact: Stéphanie HAÏAT
Principal Investigator: Stéphanie HAÏAT
Hôpital Henri Mondor
Recruiting
Créteil, France, 94010
Contact: PAUTAS Cécile cecile.pautas@hmn.aphp.fr
Principal Investigator: PAUTAS Cécile
CHU de Dijon
Not yet recruiting
Dijon, France, 21079
Contact: CAILLOT Denis denis.caillot@chu-dijon.fr
Principal Investigator: CAILLOT Denis
Centre hospitalier de Versailles
Recruiting
Le Chesnay cedex, France, 78157
Contact: Rousselot Philippe 003339638622 phrousselot@ch-versailles.fr
Principal Investigator: Rousselot Philippe
Hôpital Claude Huriez
Recruiting
Lille cedex, France, 59037
Contact: QUESNEL Bruno bquesnel@chru-lille.fr
Principal Investigator: QUESNEL Bruno
CHRU Dupuytren
Not yet recruiting
Limoges cedex, France, 87042
Contact: TURLURE Pascal pascal.turlure@chu-limoges.fr
Principal Investigator: TURLURE Pascal
Hôpital Edouard Herriot
Recruiting
Lyon cedex 03, France, 69437
Contact: THOMAS Xavier xavier.thomas@chu-lyon.fr
Principal Investigator: THOMAS Xavier
Dr Regis COSTELLO
Recruiting
Marseille, France, 13000
Contact: Regis COSTELLO regis.costello@ap-hm.fr
Principal Investigator: Regis COSTELLO
Centre Hospitalier de Meaux
Recruiting
Meaux, France, 77104
Contact: FRAYFER Jamilé j-frayfer@ch-meaux.fr
Principal Investigator: FRAYFER Jamilé
Dr Mario OJEDA-URIBE
Recruiting
Mulhouse, France, 68000
Contact: Mario OJEDA-URIBE ojedam@ch-mulhouse.fr
Principal Investigator: Mario OJEDA-URIBE
Dr Jacques DELAUNAY
Recruiting
Nantes, France, 44000
Contact: Jacques DELAUNAY jacques.delaunay@chu-nantes.fr
Principal Investigator: Jacques DELAUNAY
CHU Nice, Hôpital Archet 1
Recruiting
Nice cedex 3, France, 06202
Contact: MANNONE Lionel mannone.l@chu-nice.fr
Principal Investigator: MANNONE Lionel
CHU de Nîmes
Recruiting
Nîmes, France, 30029
Contact: Eric JOURDAN eric.jourdan@chu-nimes.fr
Principal Investigator: Eric Jourdan
Hôpital Saint Antoine
Recruiting
Paris cedex 12, France, 75751
Contact: ISNARD Françoise francoise.isnard@sat.aphp.fr
Principal Investigator: ISNARD Françoise
Hôpital Necker Enfants Malades
Recruiting
Paris cedex 15, France, 75743
Contact: SUAREZ Felipe felipe.suarez@nck.aphp.fr
Principal Investigator: SUAREZ Felipe
Hôpital Saint Louis
Recruiting
Paris, France, 75010
Contact: RAFFOUX Emmanuel emmanuel.raffoux@sls.ap-hop-paris.fr
Principal Investigator: RAFFOUX Emmanuel
Hôpital La Pitié Salpêtrière
Recruiting
Paris, France, 75013
Contact: UZUNOV Madalina madalina.uzunov@psl.aphp.fr
Principal Investigator: UZUNOV Madalina
Dr Laurence SANHES
Suspended
Perpignan, France, 66000
Dr Arnaud PIGNEUX
Recruiting
Pessac, France, 33604
Contact: Arnaud PIGNEUX arnaud.pigneux@chu-bordeaux.fr
Principal Investigator: Arnaud PIGNEUX
Centre Hospitalier René Dubos
Recruiting
Pontoise Cedex, France, 95303
Contact: VAIDA Iona Dana ioana.vaida@ch-pontoise.fr
Principal Investigator: VAIDA Iona Dana
Marc BERNARD
Recruiting
Rennes, France, 35000
Contact: Marc BERNARD marc.bernard@chu-rennes.fr
Principal Investigator: Marc BERNARD
Dr Emilie LEMASLE
Recruiting
Rouen, France, 76000
Contact: Emilie LEMASLE emilie.lemasle@chb.unicancer.fr
Principal Investigator: Emilie LEMASLE
Centre Hospitalier René Huguenin
Suspended
Saint Cloud, France, 92210
Institut de Cancérologie de la Loire
Recruiting
Saint-Priest-en-Jarez, France, 42270
Contact: Emmanuelle TAVERNIER-TARDY emmanuelle.tavernier@icloire.fr
Principal Investigator: Emmanuelle TAVERNIER-TARDY
Dr Réda GARIDI
Recruiting
Saint-Quentin, France, 02100
Contact: Réda GARIDI
Principal Investigator: Réda GARIDI
Dr Christian RECHER
Recruiting
Toulouse, France, 31000
Contact: Christian RECHER
Principal Investigator: Christian RECHER
Centre Hospitalier de Valenciennes
Recruiting
Valenciennes, France, 59322
Contact: FERNANDES José fernandes-j@ch-valenciennes.fr
Principal Investigator: FERNANDES José Collapse << |
NCT00459524 | - | - | Completed | - | United States, Texas
... more >>
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States, 77030 Collapse << |
NCT03760445 | Leukemia, Myeloid, Acute | Phase 1
Phase 2 | Not yet recruiting | October 13, 2022 | - |
NCT03609060 | Acute Myeloid Leukemia | Phase 2 | Recruiting | December 31, 2025 | France
... more >> CHU ANGERS - Maladies du sang
Recruiting
Angers, France, 49933
Contact: Mathilde HUNAULT, Dr 02 41 35 45 82 mahunault@chu-angers.fr
Ch Avignon
Not yet recruiting
Avignon, France, 84000
Contact: Safia CHEBREK, Dr +33 4 32 75 93 00 chebrek.safia@ch-avignon.fr
CH de la Côte Basque - Hématologie
Not yet recruiting
Bayonne, France, 64109
Contact: Anne BANOS, Dr +33 5 59 44 38 32 abanos@ch-cotebasque.fr
CHRU JEAN MINJOZ - Hématologie
Not yet recruiting
Besançon, France, 25030
Contact: Yohan DESBROSSES, Dr +33 3 81 66 82 32 ydesbrosses@chu-besancon.fr
CHU Brest - Hôpital Morvan - Hématologie Clinique
Not yet recruiting
Brest, France, 29609
Contact: Gaëlle GUILLERM, Dr +33 2 98 22 35 04 gaelle.guillerm@chu-brest.fr
CH de Béziers - Hématologie
Not yet recruiting
Béziers, France, 34500
Contact: Alain SAAD, Dr +33 4 67 35 70 63 alain.saad@ch-beziers.fr
Clinique du Parc - Hématologie
Not yet recruiting
Castelnau-le-Lez, France, 34170
Contact: Carole EXBRAYAT, Dr +33 4 67 33 15 12 carole.exbrayat@groupeclinipole.fr
CHU Estaing - Hématologie Clinique Adulte
Not yet recruiting
Clermont-Ferrand, France, 63000
Contact: Romain GUIEZE, Dr +33 4 73 75 00 65 rguieze@chu-clermontferrand.fr
CHU Grenoble - Hématologie Clinique
Not yet recruiting
Grenoble, France, 38043
Contact: Martin CARRE, Dr +33 4 76 76 57 55 mcarre1@chu-grenoble.fr
Institut Paoli-Calmettes - Hématologie 2
Not yet recruiting
Marseille, France, 13000
Contact: Norbert VEY, Pr +33 4 91 22 36 95 veyn@ipc.unicancer.fr
CHR de Mercy - Hématologie
Not yet recruiting
Metz, France, 57085
Contact: Véronique DORVAUX, Dr +33 3 87 55 33 04 v.dorvaux@chr-metz-thionville.fr
Hôpital Saint-Eloi - Hématologie Clinique
Not yet recruiting
Montpellier, France, 34295
Contact: Yosr HICHERI, Dr +33 4 67 33 24 18 y-hicheri@chu-montpellier.fr
HOPITAL E. MULLER - Hématologie
Not yet recruiting
Mulhouse, France, 68070
Contact: Mario OJEDA-URIBE, Dr +33(0)3 89 64 77 55 ojeda-uribem@ghrmsa.fr
CHU HOTEL DIEU - Hématologie Clinique
Not yet recruiting
Nantes, France, 44093
Contact: Pierre PETERLIN², Dr +33(0)2 40 08 32 71 pierre.peterlin@chu-nantes.fr
CHR ORLEANS - Hématologie
Recruiting
Orléans, France, 44100
Contact: Omar BENBRAHIM, Dr +33(0)2 38 22 99 27 omar.benbrahim@chr-orleans.fr
HOPITAL COCHIN - Hématologie
Not yet recruiting
Paris, France, 75014
Contact: Lise WILLEMS, Dr +33(0)1 58 41 26 70 lise.willems@aphp.fr
CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique
Not yet recruiting
Perpignan, France, 66000
Contact: Laurence SANHES, Dr +33(0)4 68 61 89 02 laurence.sanhes@ch-perpignan.fr
Hôpital Haut Levêque- CFM -Hématologie Clinique Et Thérapie Cellulaire
Not yet recruiting
Pessac, France, 33604
Contact: Arnaud PIGNEUX, Pr +33 5 57 65 65 11 arnaud.pigneux@chu-bordeaux.fr
CHU La Milétrie - Hématologie Clinique
Not yet recruiting
Poitiers, France, 86000
Contact: Maria-Pilar GALLEGO-HERNANZ, Dr +33(0)5 49 44 44 44 maria-pilar.gallego-hernanz@chu-poitiers.fr
CHU Reims - Hôpital Robert Debré - Hématologie Clinique
Not yet recruiting
Reims, France, 51100
Contact: Chantal HIMBERLIN, Dr +33(0)3 26 78 36 44 chimberlin@chu-reims.fr
CHU Pontchaillou - Hématologie
Not yet recruiting
Rennes, France, 35033
Contact: Marc BERNARD, Dr +33(0)2 99 28 99 86 marc.bernard@chu-rennes.fr
CHU Hautepierre - Hématologie
Not yet recruiting
Strasbourg, France, 67098
Contact: Bruno LIOURE, Dr +33(0)3 88 12 76 76 bruno.lioure@chru-strasbourg.fr
Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie
Recruiting
Toulouse, France, 31059
Contact: Christian RECHER, Pr +33 5 31 15 63 55 recher.christian@iuct-oncopole.fr
CHU Bretonneau - Centre Henri Kaplan - Hématologie et Thérapie Cellulaire
Not yet recruiting
Tours, France, 37044
Contact: Emmanuel GYAN, Pr +33(0)2 47 47 37 12 emmanuel.gyan@univ-tours.fr
CHU Nancy - Hopitaux Brabois
Not yet recruiting
Vandœuvre-lès-Nancy, France, 54500
Contact: Gabrielle ROTH-GUEPIN, Dr +33(0)3 83 15 76 86 g.roth-guepin@chru-nancy.fr Collapse << |
NCT02756962 | Acute Myeloid Leukemia | Phase 2 | Recruiting | July 31, 2024 | United States, Missouri
... more >>
Washington University School of Medicine
Recruiting
Saint Louis, Missouri, United States, 63110
Contact: Meagan Jacoby, M.D., Ph.D. 314-454-8304 mjacoby@wustl.edu
Principal Investigator: Meagan Jacoby, M.D., Ph.D.
Sub-Investigator: Timothy Ley, M.D.
Sub-Investigator: David Spencer, M.D., Ph.D.
Sub-Investigator: Camille Abboud, M.D.
Sub-Investigator: John DiPersio, M.D., Ph.D.
Sub-Investigator: Todd Fehniger, M.D., Ph.D.
Sub-Investigator: Armin Ghobadi, M.D.
Sub-Investigator: Brad Kahl, M.D.
Sub-Investigator: Iskra Pusic, M.D.
Sub-Investigator: Mark Schroeder, M.D.
Sub-Investigator: Keith Stockerl-Goldstein, M.D.
Sub-Investigator: Geoffrey Uy, M.D.
Sub-Investigator: Ravi Vij, M.D.
Sub-Investigator: Matthew Walter, M.D.
Sub-Investigator: Lukas Wartman, M.D.
Sub-Investigator: John Welch, M.D., Ph.D.
Sub-Investigator: Peter Westervelt, M.D., Ph.D.
Sub-Investigator: Amanda Cashen, M.D.
Sub-Investigator: Tanya Wildes, M.D.
Sub-Investigator: Terrence Wong, M.D. Collapse << |
NCT02115295 | Leukemia | Phase 2 | Recruiting | May 2019 | United States, Texas
... more >>
University of Texas MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030 Collapse << |
NCT03092674 | Acute Myeloid Leukemia
... more >> Myelodysplastic Syndrome
Myelodysplastic Syndrome With Excess Blasts-2
Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 2
Phase 3 | Suspended(Other - Safety data ... more >>review, unscheduled) Collapse << | August 1, 2023 | - |
NCT03258931 | Newly Diagnosed FLT3 Mutated A... more >>ML Collapse << | Phase 3 | Recruiting | November 2024 | United States, California
... more >>
US Davis Health
Recruiting
Sacramento, California, United States, 95817
Contact: Brian Jonas, MD 800-282-3284 bajonas@ucdavis.edu
United States, Florida
Moffitt Cancer Center
Recruiting
Tampa, Florida, United States, 33612
Contact: Kendra Sweet, MD 813-745-6841 Kendra.Sweet@moffitt.org
United States, Kansas
University of Kansas
Recruiting
Kansas City, Kansas, United States, 66160
Contact: Sunil Abhyankar, MD 913-588-9281 sabhyankar@kumc.edu
United States, Massachusetts
Dana-Farber Cancer Insitute
Recruiting
Boston, Massachusetts, United States, 02215
Contact: Richard M Stone, MD 617-632-2214 Richard_Stone@dfci.harvard.edu
United States, Michigan
Karmanos Cancer Institute
Recruiting
Detroit, Michigan, United States, 48201
Contact: Jay Yang, MD 800-527-6266 yangj@karmanos.org
Henry Ford Health System
Recruiting
Detroit, Michigan, United States, 48202
Contact: Yue Guo, MD 800-436-7936 YGUO1@hfhs.org
United States, New York
Roswell PArk
Recruiting
Buffalo, New York, United States, 14263
Contact: Eunice S Wang, MD 716-845-3544 eunice.wang@roswellpark.org Collapse << |
NCT02078609 | AML and High Risk MDS | Phase 1 | Recruiting | September 3, 2019 | United States, Michigan
... more >>
Novartis Investigative Site
Recruiting
Ann Arbor, Michigan, United States, +1 48109 0944
Contact: Sabrina Pelton Hargrove +1 734 936 8538 sgomes@med.umich.edu
Principal Investigator: Dale Bixby
United States, Texas
Novartis Investigative Site
Recruiting
Houston, Texas, United States, 77030
Australia, Victoria
Novartis Investigative Site
Recruiting
Prahran, Victoria, Australia, 3181
France
Novartis Investigative Site
Completed
Marseille, France, 13273
Germany
Novartis Investigative Site
Completed
Ulm, Germany, 89081
Italy
Novartis Investigative Site
Recruiting
Milano, MI, Italy, 20132
Novartis Investigative Site
Recruiting
Milano, MI, Italy, 20162
Novartis Investigative Site
Recruiting
Roma, RM, Italy, 00133
Japan
Novartis Investigative Site
Recruiting
Shinagawa-ku, Tokyo, Japan, 141 8625
Netherlands
Novartis Investigative Site
Recruiting
Amsterdam, Netherlands, 1081 HV Collapse << |
NCT00651261 | Leukemia | Phase 3 | Active, not recruiting | - | - |
NCT01093573 | Untreated Adult Acute Myeloid ... more >>Leukemia Collapse << | Phase 1
Phase 2 | Unknown | - | United States, Ohio
... more >>
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106
United States, West Virginia
West Virginia University
Morgantown, West Virginia, United States, 26506 Collapse << |
NCT02634827 | Acute Myeloid Leukemia With FL... more >>T3/ITD Mutation
Acute Myeloid Leukemia With Gene Mutations
FLT3 Tyrosine Kinase Domain Point Mutation
Secondary Acute Myeloid Leukemia
Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 2 | Active, not recruiting | April 15, 2020 | United States, Minnesota
... more >>
Mayo Clinic
Rochester, Minnesota, United States, 55905 Collapse << |
NCT03686345 | Core Binding Factor Acute Myel... more >>oid Leukemia (CBF-AML) Collapse << | Phase 2 | Active, not recruiting | December 31, 2025 | Italy
... more >> Ospedale Cà Granda - Niguarda S.C: Ematologia
Milano, Italy, 20162 Collapse << |
NCT01477606 | Acute Myeloid Leukemia | Phase 2 | Active, not recruiting | June 2020 | - |
NCT00651261 | - | - | Active, not recruiting | - | - |
NCT00782067 | Leukemia | Phase 2 | Completed | - | - |
NCT01161550 | Leukemia, Myeloid, Acute | Phase 1 | Completed | - | United States, Missouri
... more >>
Washington University School of Medicine
St. Louis, Missouri, United States, 63110 Collapse << |
NCT00782067 | - | - | Completed | - | - |
NCT03591510 | FLT3-mutated Acute Myeloid Leu... more >>kemia Collapse << | Phase 2 | Not yet recruiting | April 21, 2025 | Korea, Republic of
... more >>
Novartis Investigative Site
Seoul, Korea, Republic of, 03080 Collapse << |
NCT01174888 | Acute Myeloid Leukemia
... more >> Acute Myeloid Leukemia With Multilineage Dysplasia Following
Myelodysplastic Syndrome
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Recurrent Adult Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia Collapse << | Phase 1 | Completed | - | United States, Ohio
... more >>
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210 Collapse << |
NCT00233454 | - | - | Completed | - | - |
NCT00233454 | Systemic Mastocytosis, Aggress... more >>ive (ASM)
Leukemia, Mast Cell
Hematological Non-mast Cell Lineage Disease (AHNMD) Collapse << | Phase 2 | Completed | - | United States, California
... more >>
Stanford University School of Medicine
Stanford, California, United States, 94305
United States, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, Missouri
Washington University-St. Louis
Saint Louis, Missouri, United States, 63110 Collapse << |
NCT00045942 | Acute Myeloid Leukemia
... more >> Myelodysplastic Syndromes Collapse << | Phase 1
Phase 2 | Completed | - | United States, California
... more >>
UCLA Medical Center
Los Angeles, California, United States, 90095
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, New York
New York Weill Cornell Medical Center
New York, New York, United States, 10021
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065 Collapse << |
NCT02723435 | Acute Myeloid Leukemia With Ge... more >>ne Mutations
Adult Acute Myeloid Leukemia in Remission Collapse << | Phase 2 | Withdrawn(Logistical and admin... more >>istrative issues) Collapse << | - | - |
NCT03207334 | Acute Myeloid Leukemia | Phase 2 | Withdrawn(Insufficient funding... more >>) Collapse << | January 2022 | United States, Florida
... more >>
University of Florida
Gainesville, Florida, United States, 32610 Collapse << |
NCT03114228 | - | - | - | - | Canada, Ontario
... more >>
Novartis Investigative Site
Hamilton, Ontario, Canada, L8V 1C3
Canada, Quebec
Novartis Investigative Site
Montreal, Quebec, Canada, H1T 2M4 Collapse << |
NCT01130662 | Acute Myeloid Leukemia | Phase 1 | Completed | - | United States, Kansas
... more >>
University of Kansas Medical Center, Westwood Campus
Kansas City, Kansas, United States, 66205 Collapse << |
NCT00093600 | Acute Myeloid Leukemia (AML) | Phase 1 | Completed | - | United States, California
... more >>
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, United States, 90095-1781
United States, Massachusetts
Dana Faber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, Michigan
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, United States, 48201-2014
United States, Texas
MD Anderson Cancer Center/University of Texas
Houston, Texas, United States, 77030
Germany
Novartis Investigative Site
Dresden, Germany
Novartis Investigative Site
Mainz, Germany Collapse << |
NCT01429337 | Hepatic Impairment | Phase 1 | Recruiting | August 14, 2019 | United States, Texas
... more >>
Novartis Investigator site
Not yet recruiting
Houston, Texas, United States, 77030
Novartis Investigator site
Not yet recruiting
San Antonio, Texas, United States, 78215
Belgium
Novartis Investigative Site
Terminated
Bruxelles, Belgium, 1200
Bulgaria
Novartis Investigative Site
Recruiting
Sofia, Bulgaria, 1618
Germany
Novartis Investigative Site
Terminated
Berlin, Germany, 14050
Novartis Investigative Site
Terminated
Frankfurt, Germany, 60590
Lithuania
Novartis Investigator site
Not yet recruiting
Kaunas, Lithuania, LT-50161
Poland
Novartis Investigative Site
Terminated
Warszawa, Poland, 02 106
Romania
Novartis Investigative Site
Recruiting
Cluj, Napoca, Romania, 400006 Collapse << |
NCT01920204 | Indolent Systemic Mastocytosis | Phase 2 | Unknown | May 2015 | Netherlands
... more >> University Medical Center Groningen
Groningen, Netherlands, 9700RB Collapse << |
NCT03280030 | Acute Myeloid Leukemia | Phase 2 | Recruiting | June 20, 2022 | Hong Kong
... more >> Novartis Investigative Site
Recruiting
Hong Kong, Hong Kong
Japan
Novartis Investigative Site
Recruiting
Nagoya-city, Aichi, Japan, 466-8650
Novartis Investigative Site
Recruiting
Toyoake city, Aichi, Japan, 470 1192
Novartis Investigative Site
Recruiting
Kashiwa, Chiba, Japan, 277-8577
Novartis Investigative Site
Recruiting
Matsuyama-city, Ehime, Japan, 790-8524
Novartis Investigative Site
Recruiting
Fukuoka city, Fukuoka, Japan, 812-8582
Novartis Investigative Site
Recruiting
Fukuyama city, Hiroshima, Japan, 720-0001
Novartis Investigative Site
Recruiting
Isehara-city, Kanagawa, Japan, 259-1193
Novartis Investigative Site
Recruiting
Kochi city, Kochi, Japan, 781-8555
Novartis Investigative Site
Recruiting
Nagasaki-city, Nagasaki, Japan, 852-8501
Novartis Investigative Site
Recruiting
Sayama, Osaka, Japan, 589 8511
Novartis Investigative Site
Recruiting
Shimotsuke city, Tochigi, Japan, 329-0498
Novartis Investigative Site
Recruiting
Bunkyo-ku, Tokyo, Japan, 113-8677
Novartis Investigative Site
Recruiting
Shinagawa-ku, Tokyo, Japan, 141 8625
Korea, Republic of
Novartis Investigative Site
Recruiting
Seoul, Korea, Republic of, 03722
Taiwan
Novartis Investigative Site
Recruiting
Putzu City, Chiayi Hsien, Taiwan, 61363
Novartis Investigative Site
Recruiting
Kaohsiung City, Taiwan, 83301
Novartis Investigative Site
Recruiting
Taipei, Taiwan, 10002
Novartis Investigative Site
Recruiting
Taoyuan, Taiwan, 33305 Collapse << |
NCT00045942 | - | - | Completed | - | - |
NCT00866281 | Acute Myeloid Leukemia
... more >> Acute Lymphoblastic Leukemia Collapse << | Phase 1
Phase 2 | Terminated(Despite considerabl... more >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) Collapse << | - | United States, Washington
... more >>
Seattle Children's Hospital CPKC412A2114
Seattle, Washington, United States, 98105
France
Novartis Investigative Site
Paris Cedex 19, France, 75935
Italy
Novartis Investigative Site
Genova, GE, Italy, 16147
Novartis Investigative Site
Monza, MB, Italy, 20900
Novartis Investigative Site
Roma, RM, Italy, 00165
Novartis Investigative Site
Torino, TO, Italy, 10126
Netherlands
Novartis Investigative Site
Rotterdam, Netherlands, 3015 GJ
Sweden
Novartis Investigative Site
Stockholm, Sweden, SE-171 76 Collapse << |
NCT01846624 | Acute Myeloid Leukemia (AML) W... more >>ith Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
AML (Adult) With 11q23 (MLL) Abnormalities
AML (Adult) With Del (5q)
AML (Adult) With Inv (16) (p13; q22)
AML (Adult) With t (16;16) (p13; q22)
AML (Adult) With t (8; 21) (q22; q22)
Secondary AML (Adult)
Untreated AML (Adult) Collapse << | Phase 2 | Terminated(Accrual factor) | - | United States, California
... more >>
Stanford University School of Medicine
Stanford, California, United States, 94305 Collapse << |
NCT01846624 | - | - | Terminated(Accrual factor) | - | - |
NCT01282502 | Adenocarcinoma of the Rectum | Phase 1 | Completed | - | United States, Massachusetts
... more >>
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215 Collapse << |
NCT00819546 | Acute Myeloid Leukemia
... more >> Myelodysplastic Syndrome Collapse << | Phase 1 | Active, not recruiting | December 2019 | United States, Massachusetts
... more >>
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215 Collapse << |
NCT01883362 | Acute Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT02624570 | - | - | - | - | - |
NCT03379727 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 30, 2021 | - |
NCT00866281 | - | - | Terminated(Despite considerabl... more >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) Collapse << | - | - |
NCT01202877 | - | - | Completed | - | - |
NCT01202877 | Leukemia | Phase 1
Phase 2 | Completed | - | United States, Texas
... more >>
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030 Collapse << |
NCT01830361 | Acute Myeloid Leukemia | Phase 2 | Active, not recruiting | September 2020 | Germany
... more >> Klinikum Chemnitz gGmbH, Klinik für Innere Medizin III
Chemnitz, Germany
Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I
Dresden, Germany
Marien Hospital
Düsseldorf, Germany
Universitätsklinikum Erlangen, Medizinische Klinik 5
Erlangen, Germany
Klinikum der Johann-Wolfgang-Goethe Universität
Frankfurt Main, Germany
Universitätsklinikum Heidelberg
Heidelberg, Germany
Universitätsklinikum Jena, Klinik für Innere Medizin II
Jena, Germany
Universitätsklinikum Gießen und Marburg GmbH
Marburg, Germany
Universitätsklinikum Münster
Münster, Germany
Städtisches Klinikum Nord
Nürnberg, Germany
Klinikum der Universität Regensburg
Regensburg, Germany Collapse << |
NCT03512197 | Acute Myeloid Leukemia (AML) | Phase 3 | Recruiting | April 28, 2026 | - |